EMEA-000279-PIP01-08-M05
Key facts
| Invented name |
Isentress
|
| Active substance |
Raltegravir
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0155/2016
|
| PIP number |
EMEA-000279-PIP01-08-M05
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe) Inc.
Tel.: +33180464738 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000279-PIP01-08-M05
|
| Compliance opinion date |
19/06/2017
|
| Compliance outcome |
positive
|